Abstract
Baby skin care is arguably an area of maternity service provision considered to be of relatively lower priority compared to antenatal and intrapartum care. However, with the rising prevalence of childhood atopic eczema in the United Kingdom and uncertainties amongst midwives and parents about effective and safe baby skin care practices, current baby skin care advice given to parents by health professionals may be a contributory factor.
There are structural differences between baby and adult skin. The epidermis in babies is 20% thinner and the stratum corneum is 30% thinner (Stamatas et al. 2010) , increasing susceptibility to permeability and dryness. The ratio of baby body surface to body weight is higher than that for adults (Nikolovski et al. 2008) , which means that topical agents may have a more intense effect on baby skin. Baby skin also has a propensity to greater trans-epidermal water loss [TEWL] and reduced stratum corneum hydration, reflecting a less effective skin barrier function (Chiou and Blume-Peytavi 2004; Nakagawa et al. 2004 ). Babies have a higher skin surface pH (low acidity) which amplifies protease activity and the breakdown of corneodesmosomes, the supportive connective components of the stratum corneum Hachem et al. 2003) . At birth, baby skin barrier is adequately developed to tolerate extrauterine environment; however, it continues to develop throughout the initial years of life (Fluhr et al. 2011; Stamatas et al. 2011; Nikolovski et al. 2008) .
Babies are susceptible to reduced epidermal barrier function. Clinical care and advice should be based on evidence-based recommendations about suitable topical agents which do not adversely alter or affect the skin barrier. This cautionary attitude is necessary in view of the increasing prevalence of childhood atopic eczema (Gupta et al. 2004; Taylor et al. 1984) , affecting over 20% of children (Flohr and Mann 2014) . This is not caused solely by genetic predisposition, but may be associated with environmental factors including the use of topically applied natural and/or commercial skin care products (Danby et al. 2013; .
Maternity and child health professionals input into parental practices years. Most atopic eczema is diagnosed during the first year (Bieber 2008) , most commonly around six months of age (Wadonda-Kabondo et al. 2003) .
Parents have a choice of a wide range of products for baby skin, but there is insufficient evidencebased guidance to employ Lavender et al. 2009 ). As traditional and anecdotal advice may be doing more harm than good, this systematic review was conducted with the aim of identifying the best available evidence to offer parents and health professionals information about optimum safe and effective skin care practices for term, healthy, newborn babies.
Methods
The systematic review focused on common aspects of skin care including bathing, cleansing, nappy care, care of the hair/scalp, managing dry skin and baby massage. The age range for the review (birth to six months) was informed by the need to provide evidence to protect the integrity of newborn baby skin and prevent atopic eczema.
Search process
A detailed search strategy was developed (Table 1 ) and tested using PICO (Richardson et al. 1995) . To enhance the retrieval of qualitative papers a further search strategy was developed (Table 2) using SPIDER (Cooke et al. 2012) . Appropriate Boolean operators were used to combine keywords. Table 3 provides an example of the full PICO search using Ovid Medline. References were managed in Endnote. A PRISMA flow diagram (Figure 1 ) represents the search process (Moher et al. 2009 ). The systematic three-step search, conducted in November 2015, employed the following databases: In addition to the electronic database search the strategy included a citation search of retrieved papers and website exploration for major pharmaceutical and cosmetic companies; and an electronic search of the most topic relevant journals. English-language studies presented in abstract form were included if sufficient data were available or from contact with the study author.
[Please insert Tables 1-3 and Figure 1 about here]
Eligibility criteria
All randomised [RCT] and quasi-randomised controlled trials (including trials in which the baby served as his/her own control), non-controlled trials and non-randomised experimental studies comparing the effects of any skin care regimens with an alternative or with no treatment were included. Qualitative papers were also included. Included papers were published in English between 2000 and 2015. This period was specified by the funder but earlier papers were included if regimens reflected current practice after review team agreement for completeness.
N
+0 weeks gestation) babies receiving common aspects of skin care from birth until six months of age were included. We excluded preterm (<37 +0 weeks gestation) babies, poorly term babies on neonatal units, or term babies with nappy rash, atopic eczema/dermatitis or receiving related treatment.
Primary outcomes included the change in stratum corneum hydration [termed hydration hereafter], TEWL and skin surface pH within six months post-birth. Secondary outcomes included the change in skin assessment scores, erythema/rash, maternal satisfaction, systemic or cutaneous infection, atopic eczema, Neonatal Behavioural Assessment Scale (NBAS: Brazelton et al. 1987) , economic analysis of skin care regimen and other skin-related outcomes not identified a priori by the research team but reported by study authors.
Data collection and analysis
The process of quality appraisal, data extraction and analysis was guided by NICE (2014a). Two reviewers independently assessed all titles/abstracts of studies identified for inclusion. A form was designed for data extraction. For eligible studies, at least two reviewers extracted data. There were no discrepancies that required resolving by a third reviewer during eligibility screening or data extraction. Where the eligible studies were those authored by one of the team, an alternative member of the review team extracted and quality appraised data.
We contacted authors where study information was unclear, particularly where means and standard deviations were missing for continuous outcomes. Where possible, missing means and standard deviations were estimated from the sample size and 5-number summary (Inoue et al. 2013; Bland 2015) or, if quartiles were not available, from the sample size, median, maximum and minimum (Iarkowski et al. 2013; Hozo et al. 2005) . Due to the expected skewness of outcome variables, missing means and standard deviations were not estimated when only medians and quartiles were available (Higgins and Green 2009) .
Studies were quality assessed independently by two reviewers using the assessment tools (Effective Public Health Practice Project 2013; Spencer et al. 2003) recommended by NICE (2014a). For quantitative studies, quality assessment was presented by outcome using the GRADE approach (Kataoka et al. 2010; Guyatt et al. 2008) :
Strong further research is very unlikely to change our confidence in the estimate of effect Moderate further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate Weak further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate For qualitative studies, quality assessment was presented by individual study using the grading strategy developed by Downe et al. (2009) based on Lincoln & Guba (1985) .
Meta-analysis was performed for quantitative data using Review Manager 5.3 when data from more than one study were available for an outcome. Forest plots highlight the individual study results together with the pooled estimate. Mean differences and odds ratios were used as the effect sizes for continuous and dichotomous outcomes respectively, except for comparisons of studies using tools to measure TEWL where the tools were known to produce readings that were not directly comparable. For such meta-analyses, standardised mean differences were used as effect sizes. Fixed-2 P random-effect models were fitted (Higgins and Green 2009) . Because of a lack of consistency in outcomes, the maximum number of studies in a meta-analysis was only three. Meta-analysis results are reported to facilitate any future systematic review but should be interpreted with caution.
Where meta-analysis was not possible, the summary of evidence includes descriptive statistics (mean values and standard deviations), effect sizes with confidence intervals [CI] , and p-values. A narrative summary is presented to highlight evidence gaps, key factors affecting the results, their interpretation and summary of the key findings. No meta-analyses of subgroups of studies were performed because no more than three studies were found for any outcome. For the qualitative evidence, meta-synthesis was not possible due to insufficient evidence, quality or reporting. Data were aggregated in narrative form.
Findings

Overview of studies
We screened 3,062 papers; 2,929 did not meet the eligibility criteria ( Figure 1 ). We included 26 eligible studies in 26 primary publications (Table 4) . Studies included 16 RCTs, 3 non-randomised 6 experimental studies (including one pilot study), 1 mixed methods study (questionnaire/interview), and 6 qualitative studies. Most reports were of two-arm trials, but two were three-arm trials (Cooke et al. 2016; Dizon et al. 2010 ) and one was a four-arm trial (Garcia-Bartels et al. 2010 ). There were no economic or observational research papers which fulfilled the eligibility criteria. There were no eligible ongoing studies within the Clinical Trials Registry (www.clinicaltrials.gov).
[Please insert Table 4 about here]
We screened the full-text of 107 papers which did not meet the inclusion criteria. Of these, nine potentially eligible studies were excluded due to missing/unpublished data which was requested from the authors but not received at time of analysis (Coret et al. 2014; Gunt et al. 2014; Hengge 2014; Tierney and Schmalenberg 2014; Iarkowski et al. 2013; Inoue et al. 2013; Kataoka et al. 2010; Baig-Lewis et al. 2009; Takahashi et al. 2009 ). At the time of analysis, TEWL and hydration data were unavailable from Simpson et al. (2010) and hydration, skin surface pH, skin assessment score and skin colonization data were unavailable from Garcia Bartels et al. (2012) . There were no identified studies investigating NBAS or economic analysis of skin care regimens. No papers were excluded due to poor quality.
Demographic characteristics
Included studies were mainly conducted post-2000. One pre-2000 study identified during citation checking (Rush 1986 ) was agreed for inclusion as it remained relevant. There were seven pre-2000 studies identified but excluded due to outdated clinical practices. Studies were conducted in high (UK, USA, Canada, Germany, Italy, Japan, Norway, Australia), middle (South Africa, Brazil, Pakistan, Zambia, Nigeria, Philippines) and low income settings (Tanzania, Ethiopia, Nepal).
In total, 10,167 babies participated in the quantitative studies. Most were born after 37 +0 weeks gestation, excepting 4% preterm per treatment group in Cutland et al. (2009) and one preterm baby per group in Kvenshagen et al. (2014) . Data from these groups were included as they were homogeneous and did not skew the data. All babies weighed in excess of 3000g.
Interventions generally commenced within the first week post-birth, continuing for 4-8 weeks. Four studies continued the intervention for 6-24 months (Kvenshagen et al. 2014; Horimukai et al. 2014; Simpson et al. 2014; . Application frequency ranged from once only to daily application for bathing and cleansing, and from twice daily to once weekly for dry skin management. Nappy care studies included frequency of every nappy change. Body treatment sites included forehead, abdomen, thigh, buttock, calf, forearm, popliteal fossa, umbilicus and fontanelle. There were no set doses to treatments except Lavender et al. (2013) Table 5 illustrates the risk of bias for quantitative studies (n=20). Methods for adequate allocation concealment were reported in 12 trials. Of the remaining eight studies, three were not randomised and five did not report randomisation methods. In skin care studies it is not always possible to blind the participants as there may be no control product or emollient that has no effect on the skin. The participants were blinded to the intervention in only three studies (Cutland et al. 2009; Muggli 7 2009; Da Cunha et al. 2008) . In one study, participants knew that they were in an intervention group but were blind to which intervention (Cooke et al. 2016) . Assessors were blinded in 11 out of 19 studies. For one study (Muggli 2009 ) this is unclear. Fourteen studies achieved complete/near complete (>80%) evaluation of outcomes. Four studies achieved 71-79% evaluation of outcomes and this information was not reported in two studies. All of the declared outcomes appear to have been reported in all studies. Data collection methods were also assessed for validity and reliability (interrater reliability and instrument calibration). Methods appeared to be valid and reliable in only two studies and were not reported in four studies. In 14 studies the reported methods appear to be valid but we were unable to confirm that reliability was assessed.
Risk of bias in included quantitative studies
[Please insert Table 5 about here]
Specific skin care comparisons
There were no data for review outcomes for hair/scalp care or for baby massage. Findings are presented for bathing and cleansing (8 comparisons), nappy care (2 comparisons) and management of dry skin (5 comparisons).
Bathing and Cleansing
Comparison 1: Newborn skin bathing and cleansing with Johnson's® baby top-to-toe® bath to water alone Dizon et al. 2010; Garcia-Bartels et al. 2010) Strong evidence from two RCTs and moderate evidence from two RCTs in this comparison showed no evidence of any difference between Johnson's® baby top-to-toe® bath and water alone for any outcome measurements (TEWL; hydration; skin surface pH; skin assessment scores; erythema; maternal satisfaction; skin colonization) at any assessment time-points (2, 4 and 8 weeks) or at any treatment site (abdomen; thigh; forearm).
Only two of the 17 outcome measurements for TEWL, hydration and skin surface pH (at abdomen at 4 weeks and thigh at 4 weeks) had comparable data that were derived from at least three studies.
TEWL at 4 weeks post-birth indicated evidence of moderate heterogeneity at the abdomen (I 2 =35%) and considerable heterogeneity at the thigh (I 2 =63%). A random-effect model was fitted for the latter. The pooled effects at the abdomen (standardised mean difference -0.05, 95% CI -0.26 to 0.15, 3 studies, 361 babies) and thigh (standardised mean difference -0.10, 95% CI -0.50 to 0.30, 3 studies, 362 babies) were not significantly different from zero (figures 2 and 3). Skin surface pH at 4 weeks post-birth indicated evidence of considerable heterogeneity at the abdomen and thigh (I 2 =97% for both). A random-effects model was fitted. The effect for the 8 smallest study significantly favoured the wash product at the abdomen and thigh but this was in a different direction to the non-significant effects for larger studies. The pooled effects at the abdomen (mean difference -0.11, 95% CI -0.55 to 0.34, 3 studies, 360 babies) and thigh (-0.09, 95% CI -0.50 to 0.31, 3 studies, 360 babies) were not significantly different from zero (figures 6 and 7). Moderate evidence from one RCT for this comparison was complicated by the intervention arm testing two products together (Johnson's® baby top-to-toe® bath and Penaten® Baby Caring Facial and Body Cream) against water alone. There was no clear pattern in the evidence for some of the measurements (TEWL; hydration; skin surface pH) at any assessment time-points (2, 4 and 8 weeks) or at any treatment site (abdomen; thigh; forehead). Other outcomes (skin assessment scores; skin colonization) showed no significant difference for any treatment site or time-point.
Comparison 3: Liquid baby cleanser and almond oil vs. water (Roberta et al. 2014) Weak evidence from one RCT for this comparison indicated higher TEWL in the group using an undefined liquid baby cleanser and almond oil compared to the group using water alone at 10 days at both the forearm and the popliteal fossa. Results are complicated by there being two treatments in the intervention arm and so individual effects cannot be determined.
Comparison 4: Baby Sebamed® Baby Liquid Cleanser vs. water (Dizon et al. 2010) Moderate evidence from one RCT for this comparison indicates no evidence of any difference between Baby Sebamed® Baby Liquid Cleanser and water alone for any measurements (TEWL; hydration; skin surface pH; skin assessment scores; maternal satisfaction) at 7 days at the calf. (Dizon et al. 2010) Moderate evidence from one RCT for this comparison indicates no evidence of any difference between Johnson's® baby top-to-toe® bath and Baby Sebamed® Baby Liquid Cleanser for any measurements (TEWL; hydration; skin surface pH; skin assessment scores; maternal satisfaction) at 7 days at the calf.
Comparison 5: Johnson's® baby top-to-toe® bath vs. Baby Sebamed® Baby Liquid Cleanser
Comparison 6: Chlorhexidine wipes vs. water (Cutland et al. 2009) Strong evidence from one RCT for this comparison indicates no evidence of any difference between chlorhexidine wipes and water alone for infection at 3 days.
Comparison 7: Chlorhexidine 0.4% liquid soap vs. pH neutral liquid soap (Da Cunha et al. 2008) Moderate evidence from one RCT for this comparison indicates no evidence of any difference between chlorhexidine 0.4% liquid soap and pH neutral liquid soap for infection at 30 minutes or 24 hours after bathing; for skin colonization the effect favoured chlorhexidine 0.4% liquid soap.
Comparison 8: pH neutral soap vs. water (Medves and O'Brien 2001; Rush 1986) Weak evidence from two RCTs for this comparison indicates no evidence of any difference between pH neutral soap and water alone for skin colonization at the umbilicus or the fontanelle at 60 minutes or 24 hours after bathing or at the umbilicus at 4 days after bathing.
Nappy care
Comparison 1: Alcohol free baby wipe vs. water Garcia-Bartels et al. 2012; Lavender et al. 2012) There was strong evidence from one RCT and one mixed-method study (structured interviews and diaries), and moderate evidence from one RCT for this comparison, but complete data from the RCTs were only available for TEWL. TEWL was consistently but not significantly lower in the group using baby wipes at 4 weeks on the buttock. Maternal satisfaction was also higher in the baby wipe group. There was no evidence of any difference between baby wipes and water alone for hydration, erythema or skin colonization. For skin surface pH the effect favoured cotton wool and water.
Comparison 2: Penaten® cream vs. Efamol® evening primrose oil (Muggli 2009) Weak evidence from one RCT for this comparison indicates no evidence of any difference between newborn nappy care with Penaten® cream and Efamol® evening primrose oil at the buttock during an eight week treatment period for babies between the age of 2 weeks and 6 months.
Management of dry skin
Comparison 1: Olive oil vs. no oil (Cooke et al. 2016) Strong evidence from one RCT for this comparison indicates that olive oil impedes the development of the lipid structure of the skin barrier; however the skin was more hydrated in the olive oil group (dual effect explained by triglyceride lipolysis). There was no difference in TEWL, skin surface pH, erythema or skin assessment score between the groups.
Comparison 2: Sunflower oil vs. no oil (Cooke et al. 2016) Strong evidence from one RCT for this comparison indicates that sunflower oil impedes the development of the lipid structure of the skin barrier; however, the skin was more hydrated in the sunflower oil group (dual effect explained by triglyceride lipolysis). There was no difference in TEWL, skin surface pH, erythema or skin assessment score between the groups.
Comparison 3: Olive oil vs. sunflower oil (Cooke et al. 2016) Strong evidence from one RCT for this comparison indicates no difference in change in lipid structure, TEWL, hydration, skin surface pH, erythema or skin assessment scores between the olive oil and sunflower oil groups.
Comparison 4: Emollient vs. no treatment (Horimukai et al. 2014; Simpson et al. 2014; Lowe et al. 2012; Garcia-Bartels et al. 2011; Strong evidence from one RCT, moderate evidence from one RCT and weak evidence from two RCTs and two experimental studies for this comparison indicates that overall, for hydration the effect favoured using emollient, particularly at 4 weeks and 8 weeks. There was no clear pattern in the evidence for TEWL or skin surface pH. Other outcomes (skin assessment scores; infection) had no significant difference between treatment groups. Incidence of atopic eczema was reduced at 26 weeks in babies using emollient in two studies. However, babies using emollient were less likely to develop eczema at 32 weeks in one study but with no significant difference between the groups (although this is just outside the upper age range for babies in the review).
Comparison 5: Daily oil bath vs. normal care (Kvenshagen et al. 2014) Weak evidence from one experimental study for this comparison indicates no difference in absence of xerosis or incidence of atopic eczema between the daily oil bath and normal care groups. Table 6 illustrates the included qualitative study characteristics: seven studies included for review were conducted in the UK, Pakistan, Nepal, Nigeria, Ethiopia, Zambia and Tanzania. Three studies were qualitative only (Adejuyigbe et al. 2015; Sacks et al. 2015; Lavender et al. 2009 ); four were mixed-methods of which for three (Shamba et al. 2014; Fikree et al. 2005; Mullany et al. 2005 ) only the qualitative component fulfilled the inclusion criteria, and for one ) both components were included in the review.
Qualitative synthesis
[Please insert Table 6 about here] Three studies were methodologically strong (Shamba et al. 2014; Furber et al. 2012; Lavender et al. 2009 ) with a clear sampling strategy, data collection and analysis strategy and reporting, and a clear and cohesive link between the data, the interpretation and the conclusions. Two studies were of poor methodological quality (Fikree et al. 2005; Mullany et al. 2005) : sampling strategy was unclear, and there was no thematic analysis or interpretation. In one study (Fikree et al. 2005) there was a superficial link between the data and conclusion, but for the other (Mullany et al. 2005 ) no data were presented. There was a similar lack of evidence of thematic analysis and link between the data and conclusions in Sacks et al. (2015) ; however this study was graded as moderate quality due to acknowledging reflexivity, ethical consideration and clear sampling and data collection strategies. Adejuyigbe et al. (2015) was also graded as moderate quality. This study was well designed and conducted, but there was no acknowledgement of reflexivity and the sample size was unclear.
Due to the dearth of qualitative evidence with similar focus, metasynthesis was inappropriate. Only five studies were deemed to be sufficiently robust for synthesis (Adejuyigbe et al. 2015; Sacks et al. 2015; Shamba et al. 2014; Furber et al. 2012; Lavender et al. 2009 ); however, their aims were not congruent. The three African studies focused on thermal care, limiting transferability to UK settings. The two UK studies considered different aspects of baby skin care. These papers were therefore considered narratively.
African studies found that traditional, cultural and symbolic factors influence practices which may be harmful, -being, early and frequent baby bathing, night bathing with cold water and applying harmful substances to the skin such as cooking oil, powders made of roots, burnt gourds or ash. All of these studies highlighted the need for behaviour change to improve and promote knowledge about best practice.
In both UK studies Lavender et al. 2009 ), continued even though the studies were conducted three years apart; participants were endeavouring to conform to guidelines despite not always wanting to L water alone for bathing and cleansing. Lavender et al. 2009; p116) In the later study by Furber et al. (2012) , the authors suggest that tested in the study. Furber et al. 2012; pE23) L onals were promoting topical oil for dry skin or massage, believing that traditional natural products were safer than pharmaceutical/cosmetic formulations.
Discussion
What does this review add to existing knowledge?
This review can assist health professionals in consolidating their knowledge of baby skin care. This robust critical appraisal and synthesis offers the best available evidence and can be used by health professionals to support informed choice for women and families about baby skin care.
Until recently, there has been little robust research or its appraisal or synthesis to guide practice in safe and effective baby skin care. Consequently, health professionals have used tradition and personal experience to guide women ). Now stronger evidence is emerging which demonstrates that specific baby wash and wipes products are equivalent to water alone in relation to key outcomes of TEWL, hydration, skin surface pH, skin assessment scores and erythema. Other evidence indicates that daily full-body emollient application may be beneficial to prevent development of atopic eczema in babies who have a genetic predisposition. However, using topically applied olive or sunflower oil may impede the development of skin barrier function in healthy term babies.
What is the quality of the evidence base?
There was a high level of poor study reporting, an issue noted by previous reviews Crozier and Macdonald 2010) . Eighteen study authors (from 133; 14%) were contacted for eligibility queries and/or to request additional data, but only six responded. Authors conducting trials should adhere to the CONSORT RCT reporting guidance (Schultz et al. 2010) , the TREND statement for reporting non-randomised trials (Des Jarlais et al. 2004 ) and the STROBE statement for observational studies (von Elm et al. 2007 ). The review team recognised in particular that it is insufficient to report data only in graphical form, as it is impossible to read data accurately in this format. Means, standard deviations, number per group, CIs and p-values should all be reported in the text as appropriate. When distributions are skewed and medians are used to summarise the centre, they should be accompanied by maxima, minima and quartiles so that means and standard deviations can be estimated for meta-analysis. Systematic reviews are labour intensive but rank at the top of the hierarchy of evidence (Guyatt et al. 1995) . Study authors and journal editors should ensure that publications include the most complete and precise data possible.
The strength of the qualitative evidence ranged from very weak to very strong. Only five studies were deemed sufficiently robust for synthesis (Adejuyigbe et al. 2015; Sacks et al. 2015; Shamba et al. 2014; Furber et al. 2012; Lavender et al. 2009 ). Unfortunately study aims were not congruent and meta-synthesis impossible. Stronger studies had a clearer sampling strategy, data collection and analysis strategy and reporting, and a clear and cohesive link between the data, the interpretation and the conclusions. Study authors should be guided by the COREQ statement (Tong et al. 2007 ) for reporting qualitative studies to aid future meta-synthesis.
Were there any potential biases in the review process?
The primary concern in any review process is the possibility that findings are subject to publication or other reporting biases. We endeavoured to minimise any bias by screening the reference lists of included studies and searching for conference proceedings to identify studies not yet published. Meta-analyses did not contain sufficient trials to assess the funnel plots as a means of identifying publication or reporting bias.
The quality of study reporting was poor relating to both methods and data and some studies were graded as methodologically poor in the absence of further information.
What are the gaps in the evidence base?
There are a number of areas where evidence exists, but due to heterogeneity, the data could not be pooled for meta-analysis. Studies had different outcome measures, measured at different timepoints and/or on different body sites. There is a need to develop an appropriate core outcome set for baby skin care research, registered with the COMET Initiative (2016), to inform the design of future quantitative evaluative studies. Williamson et al. (2012) suggest that a core outcome set can minimise difficulties caused by heterogeneity and can also minimise outcome reporting bias. Existing work, such as the Harmonising Outcome Measures for Eczema (HOME) statement (Schmitt et al. 2014) for assessment of clinical signs of atopic eczema in trials, could inform this core outcome set. Having a core outcome set does not preclude the use of other outcome measures, but ensures a minimum core data set for comparison.
There is very little qualitative evidence preferences and the social role of bathing, or quantitative evidence investigating the economic costs of skin care regimens, optimal frequency of bathing, water hardness pertaining to newborn skin, nappy barrier creams as a prevention rather than a treatment, care of the hair and scalp and skin related outcomes for baby massage. More research is required in these areas.
Even with the review covering an age range of 0-6 months, there have been few studies with a follow-up time-point to assess any correlation between skin products used from birth and the development of atopic eczema. The most robust trial evidence (Cooke et al. 2016; Horimukai et al. 2014; Lavender et al. 2013; Garcia-Bartels et al. 2012; Dizon et al. 2010) has assessed TEWL, hydration, skin surface pH, lipid structure, skin assessment scores and erythema, all of which can be indicators of a defective skin barrier function. Unfortunately inconsistency of measured outcomes prevents pooling of data for meta-analysis.
Only two large trials (Horimukai et al. 2014; Simpson et al. 2014 ) considered incidence of atopic eczema at 6 months of age but both of these recruited from a high risk population. Only 45% of diagnoses are made in the first six months after birth and 60% in the first year of life (Bieber 2008) . Future studies investigating the impact of product use on the skin of healthy babies should aim to include this outcome at 6 and 12 months, and for longer durations if possible.
What are the implications for practice?
The review highlights the need for education and training to be developed, related to understanding the current evidence base and the impact this evidence has on clinical practice. It increases awareness of the effect of certain products on baby skin and their potential link to the development of atopic eczema. Education and training should be targeted to different audiences including health professionals, parents, hospital Trusts and service providers such as the International Association of Infant Massage. NICE Postnatal Care Guidelines (2014b) include only one relevant non-evidence-based standard (1.4.23) for baby skin care (Table 7) , which has not been updated since 2006.
[Please insert Table 7 about here] This review has shown that specific agents and wipes can be used as an alternative to water alone, highlighted in several robust clinical trials since 2006 (Cooke et al. 2016; Horimukai et al. 2014; Simpson et al. 2014; Lavender et al. 2013; Garcia-Bartels et al. 2012; Dizon et al. 2010 ). In addition, the NICE guidance also suggests that soap may be used, but soap may contain sodium lauryl sulphate (SLS) that disrupts skin barrier function . The reviewers consider that there is compelling need to revise current clinical guidance.
Conclusions
There are uncertainties amongst midwives and health professionals about effective and safe baby skin care practices. It is possible that by providing traditional and anecdotal advice to parents, which may be detrimental to skin barrier function, health professionals are a contributory factor in the rising prevalence of UK childhood atopic eczema.
This review has reported the available evidence for the five main aspects of healthy baby skin care. Twenty studies (7 strong, 4 moderate, 9 weak) were included in the quantitative review, and seven studies (3 strong, 2 moderate, 2 weak) were included in the qualitative review. It is evident that current UK clinical guidelines do not embrace the most contemporary evidence.
There is a growing body of robust evidence for bathing and cleansing, nappy care and management of dry skin, and a dearth of evidence for hair/scalp care and baby massage. Recent clinical trials investigating wash and wipe products found that a number are equivalent to water alone in their effect on skin barrier function. This means that health professionals can promote some choice to parents rather than advocating water only.
Meta-analysis was impeded by a lack of consistency of study outcome measures in many of the studies which fulfilled the review eligibility criteria. More studies could be included in meta-analysis if research in baby skin care adopted a core outcome measure set. Development of baby skin care core outcome measures is recommended.
It is imperative that the review findings are now addressed to improve education and training, and there is a compelling need to provide clear updated guidelines reflecting the appraisal and synthesis of current evidence for midwives, parents and other maternity service providers. 
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